Consolidated and separate statements of cash flowsfor the year ended 30 JUNE 2020
| Group | Company | |||||||||
| Notes | 2020 R'000 |
Restated** 2019 R'000 |
2020 R'000 |
2019 R'000 |
||||||
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||||
| Cash receipts from/(payments to) customers | 6 460 790 | 5 895 618 | (25) | 225 | ||||||
| Cash paid to suppliers and employees | (5 521 045) | (5 232 082) | (12 951) | (15 102) | ||||||
| CASH GENERATED FROM/ (UTILISED IN) OPERATIONS | 25 | 939 745 | 663 536 | (12 976) | (14 877) | |||||
| Dividend paid | 27 | (239 142) | (196 662) | (195 242) | (186 321) | |||||
| Dividends received | 4 626 | 4 168 | 56 012 | – | ||||||
| Interest paid | (71 775) | (52 008) | (7) | (61) | ||||||
| Interest received | 22 | 26 888 | 24 657 | 6 555 | 5 057 | |||||
| Income taxes (paid)/refunded | 26 | (158 634) | (136 924) | 534 | (3 861) | |||||
| Net cash inflow/(outflow) from operating activities | 501 708 | 306 767 | (145 124) | (200 063) | ||||||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||||
| Payment for acquisition of subsidiaries, net of cash acquired | – | (572 706) | – | – | ||||||
| Business combinations* | (20 350) | – | – | – | ||||||
| Proceeds from sales of tangible assets | 17 115 | – | – | – | ||||||
| Purchase of tangible assets | (136 969) | (98 857) | – | – | ||||||
| Proceeds from sales of intangible assets | – | 962 | – | – | ||||||
| Purchase of intangible assets | (284 210) | (241 697) | – | – | ||||||
| Settlement of loans by associates | – | 2 600 | – | – | ||||||
| Sale of investment | – | 3 174 | – | – | ||||||
| Settlement of loans advanced to group companies | – | – | 126 792 | – | ||||||
| Disinvestment of financial assets | – | 227 434 | 183 | 227 434 | ||||||
| Payment toward deferred payment obligation | (7 335) | (306) | – | – | ||||||
| Net cash (outflow)/inflow from investing activities | (431 749) | (679 396) | 126 975 | 227 434 | ||||||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||||
| Changes in ownership interests in subsidiaries that do not result in loss of control – Medscheme Mauritius Limited | 16 | 6 303 | – | – | – | |||||
| Lease liability capital repayment** | (58 243) | (62 652) | – | – | ||||||
| Proceeds of borrowings | 50 000 | 550 000 | – | – | ||||||
| Capital settlement of borrowings | (155 255) | (58 434) | – | – | ||||||
| Proceeds of loans from group companies | – | – | 9 767 | – | ||||||
| Repayments of loans by related parties | – | – | – | (28 046) | ||||||
| Net cash (outflow)/inflow from financing activities | (157 195) | 428 914 | 9 767 | (28 046) | ||||||
| Net (decrease)/increase in cash and cash equivalents before effect of exchange rate changes | (87 236) | 56 285 | (8 382) | (675) | ||||||
| Effect of exchange rate changes on cash and cash equivalents | (380) | (3 907) | – | – | ||||||
| Cash and cash equivalents at beginning of the year | 265 296 | 212 918 | 10 316 | 10 990 | ||||||
| Cash and cash equivalents at end of the year | 8.3 | 177 680 | 265 296 | 1 934 | 10 316 | |||||
| * | This relates to the portion of the preacquisition dividend paid to the former shareholders of Activo Health (Pty) Ltd on the date that the dividend was declared. The dividend was paid in December 2019, post the acquisition of Activo Health (Pty) Ltd in March 2019 |
| ** | Refer to Note 35.6 for the detail of the restatement. |